117 related articles for article (PubMed ID: 35647818)
1. HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition.
He YX; Song XH; Zhao ZY; Zhao H
Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3406. PubMed ID: 35647818
[TBL] [Abstract][Full Text] [Related]
2. MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail.
Fan MJ; Zhong YH; Shen W; Yuan KF; Zhao GH; Zhang Y; Wang SK
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9234. PubMed ID: 33015755
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1.
Xu L; Sun HB; Xu ZN; Han XL; Yin YY; Zheng Y; Zhao Y; Wang ZX
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2827. PubMed ID: 33877684
[TBL] [Abstract][Full Text] [Related]
4. LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3p.
Su YZ; Cui MF; Du J; Song B
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6827. PubMed ID: 34859842
[TBL] [Abstract][Full Text] [Related]
5. Retraction Note: MicroRNA-132 stimulates the growth and invasiveness of trophoblasts by targeting DAPK-1.
Wang YP; Zhao P; Liu JY; Liu SM; Wang YX
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4545. PubMed ID: 35856341
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.
Zhao X; Li D; Zhao ST; Zhang Y; Xu A; Hu YY; Fang Z
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4158. PubMed ID: 35776012
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer.
Wang ZH; Wang JH; Wang KQ; Zhou Y; Wang J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8250. PubMed ID: 32894530
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.
Zhu SM; Chen CM; Jiang ZY; Yuan B; Ji M; Wu FH; Jin J
Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3640. PubMed ID: 34109599
[TBL] [Abstract][Full Text] [Related]
9. Circ_0017247 accelerates epithelial-mesenchymal transition in non-small cell lung cancer.
Li CH; Wang YB; Chen KB
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7217. PubMed ID: 32706055
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circ-SMAD7 is downregulated in colorectal cancer and suppresses tumor metastasis by regulating epithelial mesenchymal transition.
Wang DK; Chong RF; Song BL; Fan KF; Liu YF
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9241. PubMed ID: 33015762
[TBL] [Abstract][Full Text] [Related]
11. Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9.
Liu ZH; Liu WJ; Yu XY; Qi XL; Sun CC
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3798. PubMed ID: 35731047
[TBL] [Abstract][Full Text] [Related]
12. MiR-155-5p affects Wilms' tumor cell proliferation and apoptosis via targeting CREB1.
Zhao XS; Han B; Zhao JX; Tao N; Dong CY
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6826. PubMed ID: 34859841
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CASC2 inhibits metastasis and epithelial to mesenchymal transition of lung adenocarcinoma via suppressing SOX4.
Wang D; Gao ZM; Han LG; Xu F; Liu K; Shen Y
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7210. PubMed ID: 32706048
[TBL] [Abstract][Full Text] [Related]
14. SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
Li MZ; Lai DH; Zhao HB; Chen Z; Huang QX; Situ J
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11985. PubMed ID: 33336712
[TBL] [Abstract][Full Text] [Related]
15. TUG1 promotes the development of prostate cancer by regulating RLIM.
Guo BH; Zhao Q; Li HY
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2826. PubMed ID: 33877677
[TBL] [Abstract][Full Text] [Related]
16. LncRNA AB073614 promotes tumor migration and invasion by repressing CDKN1A in non-small cell lung cancer.
Zhao WD; Zhang BX; Cui XH; Zhang J; Du N; Zhang YF
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7552. PubMed ID: 32744657
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis.
Xu T; Liu CL; Li T; Zhang YH; Zhao YH
Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3057. PubMed ID: 35587053
[TBL] [Abstract][Full Text] [Related]
18. Melatonin inhibits the inflammation and apoptosis in rats with diabetic retinopathy via MAPK pathway.
Ma Y; Zhao Q; Shao Y; Cao MZ; Zhao M; Wang D
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7545. PubMed ID: 32744650
[TBL] [Abstract][Full Text] [Related]
19. Retraction Note: The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.
Chen RY; Ju Q; Feng LM; Yuan Q; Zhang L
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(15):5311. PubMed ID: 35993622
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of a new oncogenic factor P5CR1 in gastric cancer.
Zhang CX; Li Y; Gong WH; Zhang J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8248. PubMed ID: 32894528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
